-
公开(公告)号:CA2855174C
公开(公告)日:2021-11-02
申请号:CA2855174
申请日:2012-11-09
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , BHATTA PALLAVI , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human OX40, including a bispecific antibody fusion protein that binds OX40 and human scrum albumin, wherein the antigen bound by the first antigen binding site is human OX40, and the antigen bound by the second antigen binding site is human serum albumin. The invention also relates to therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:CA2856216C
公开(公告)日:2021-01-12
申请号:CA2856216
申请日:2012-11-09
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , BHATTA PALLAVI , HEYWOOD SAM PHILIP , HUMPHREYS DAVID PAUL
Abstract: A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO: 1 or SEQ ID NO:2 and/or comprising a light chain variable domain having the sequence given in SEQ ID NO:3 or SEQ ID NO:4, in particular comprising a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 1 and SEQ ID NO:3 or a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 2 and SEQ ID NO:4. The disclosure also extends to polynucleotides encoding the antibodies or fragments, vectors comprising same and host cells capable of expressing the polynucleotides. The disclosure further includes pharmaceutical compositions comprising the antibodies or fragments and therapeutic used of any one of the same.
-
公开(公告)号:CA2666458C
公开(公告)日:2018-06-19
申请号:CA2666458
申请日:2007-10-18
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , POPPLEWELL ANDREW GEORGE , RAPECKI STEPHEN EDWARD
IPC: C07K16/24 , A61K39/395 , A61P35/00 , A61P37/06 , C12N15/13
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:CA2655874C
公开(公告)日:2017-05-02
申请号:CA2655874
申请日:2007-06-25
Applicant: UCB PHARMA SA
Inventor: RAPECKI STEPHEN EDWARD , POPPLEWELL ANDREW GEORGE , ADAMS RALPH
IPC: C07K16/24 , A61K39/395 , C12N5/20 , C12N15/13
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
-
公开(公告)号:CA2681530C
公开(公告)日:2017-03-28
申请号:CA2681530
申请日:2008-03-21
Applicant: BIOGEN IDEC INC , UCB PHARMA SA
Inventor: BURKLY LINDA C , FERRANT-ORGETTAS JANINE L , GARBER ELLEN A , HSU YEN-MING , SU LIHE , TAYLOR FREDERICK R , ADAMS RALPH , BROWN DEREK THOMAS , POPPLEWELL ANDREW GEORGE , ROBINSON MARTYN KIM , SHOCK ANTHONY , TYSON KERRY LOUISE
IPC: C12N15/13 , A61K39/395 , C07K16/28 , C12N15/63
Abstract: This invention provides binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind a CD154 (CD40L) protein. This invention also provides a chimeric, humanized or fully human antibody, antibody derivative or antibody fragment that specifically binds to an epitope to which a humanized Fab fragment comprising a variable heavy chain sequence according to SEQ ID NO: 1 and comprising a variable light chain sequence according to SEQ ID NO: 2 specifically binds. CD154 binding proteins of this invention may elicit reduced effector function relative to a second anti-CD154 antibody.
-
公开(公告)号:CY1115147T1
公开(公告)日:2016-12-14
申请号:CY141100263
申请日:2014-04-08
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , POPPLEWELL ANDREW GEORGE , RAPECKI STEPHEN EDWARD , TICKLE SIMON PETER
Abstract: Ηεφεύρεσησχετίζεταιμεέναμόριοαντισώματοςπουέχειειδικότηταγιααντιγονικούςκαθοριστέςτης IL-17, τιςθεραπευτικέςχρήσειςτουμορίουαντισώματοςκαιτιςμεθόδουςπαραγωγήςτουενλόγωμορίουαντισώματος.
-
公开(公告)号:BR112012006492A2
公开(公告)日:2016-11-22
申请号:BR112012006492
申请日:2010-09-24
Applicant: UCB PHARMA SA
Inventor: HANCOCK LAURA , ADAMS RALPH , HEYWOOD SAM PHILIP
Abstract: proteína de fusão de anticorpo multivalente, e, ligação de albumina. uma proteína de fusão de anticorpo multivalente que compreende uma porçaõ de imunoglobina, por exemplo um fragmento de fab ou fab', com uma primeira especificidade para um antígeno de interesse, e compreende ainda dois anticorpos de domínio único (dab) com especificoidade para um segundo antígeno de interesse que são par vh/vl, em que os dois anticorpos de domínio único são ligados por uma ligação de dissulfeto. também são fornecidas proteínas de fusão de anticorpo de especificidade dual particulares e outros fragmentos de anticorpo que são estabilizados por uma ligação de dissulfeto.
-
公开(公告)号:UA110358C2
公开(公告)日:2015-12-25
申请号:UAA201309003
申请日:2012-01-11
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , BAKER TERENCE SEWARD , LAWSON ALASTAIR DAVID GRIFFITHS
-
公开(公告)号:IN3451DEN2014A
公开(公告)日:2015-06-05
申请号:IN3451DEN2014
申请日:2014-04-30
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , BHATTA PALLAVI , HEYWOOD SAM PHILLIP , HUMPHREYS DAVID PAUL
Abstract: A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in SEQ ID NO: 1 or SEQ ID NO:2 and/or comprising a light chain variable domain having the sequence given in SEQ ID NO:3 or SEQ ID NO:4 in particular comprising a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 1 and SEQ ID NO:3 or a heavy chain variable domain and a light chain variable domain having the sequence given in SEQ ID NO: 2 and SEQ ID NO:4. The disclosure also extends to polynucleotides encoding the antibodies or fragments vectors comprising same and host cells capable of expressing the polynucleotides. The disclosure further includes pharmaceutical compositions comprising the antibodies or fragments and therapeutic used of any one of the same.
-
公开(公告)号:NZ613286A
公开(公告)日:2014-11-28
申请号:NZ61328612
申请日:2012-01-11
Applicant: UCB PHARMA SA
Inventor: ADAMS RALPH , BAKER TERENCE SEWARD , LAWSON ALASTAIR DAVID GRIFFITHS
IPC: C07K16/24 , A61K39/395
Abstract: Disclosed is a neutralising antibody which binds human IL-1 7A and human IL-17F having a light chain and a heavy chain wherein the variable domain of the light chain comprises the sequence AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK and the variable domain of the heavy chain comprises the sequence GFTFSDYNMA for CDR-H1, the sequence TITYEGRNTYYRDSVKG for CDR-H2 and the sequence PPQYYEGSIYRLWFAH for CDR-H3. Also disclosed is the use of such an antibody in the manufacture of a medicament for the treatment or prophylaxis of a pathological disorder that is mediated by IL-17A and/or IL-17F, or that is associated with an increased level of IL-17A and/or IL-17F.
-
-
-
-
-
-
-
-
-